Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RMC trial of methotrexate for CIDP
2005-003382-16Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methotrexate in chronic inflammatory demyelinating polyneuropathy (CIDP) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Aug 2005; status: completed.
02
Drugs
methotrexate
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2005-003382-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003382-16.